Table 4 Pondered bacterial resistance to the antimicrobials recommended for empirical treatment of urinary tract infection
Resistance to first-line therapy | Resistance to second-line therapy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Bacteria | Incidence (%) | PIV (%) | PIV (%)1 | NIT (%) | NIT (%)1 | AMX-CLA (%) | AMX-CLA (%)1 | SXT (%) | SXT (%)1 | FLU (%) | FLU (%)1 |
E. coli | 64.5 | 15.8 | 10.2 | 6.0 | 3.9 | 7.5 | 4.8 | 25.4 | 16.4 | 14.1 | 9.1 |
S. aureus | 6.0 | — | — | — | — | 8.3 | 0.5 | 15.6 | 0.9 | 18.8 | 1.2 |
P. mirabilis | 4.7 | 37.7 | 1.8 | 95.1 | 4.5 | 11.8 | 0.6 | 41.5 | 2.0 | 22.2 | 1.1 |
Klebsiella spp | 4.3 | 24.8 | 1.1 | 32.8 | 1.4 | 81.6 | 3.5 | 36.0 | 1.5 | 22.3 | 1.0 |
E. faecalis | 3.6 | — | — | 8.0 | 0.3 | 9.5 | 0.3 | 35.5 | 1.3 | 41.1 | 1.5 |
P. vulgaris | 2.7 | 59.1 | 1.6 | 97.1 | 2.6 | 32.9 | 0.9 | 57.3 | 1.5 | 25.3 | 0.7 |
P. aeruginosa | 2.4 | — | — | — | — | — | — | — | — | 44.3 | 1.1 |
Enterobacter spp | 1.9 | 46.7 | 0.9 | 39.5 | 0.8 | 83.2 | 1.6 | 39.3 | 0.7 | 25.7 | 0.5 |
Snn epidermidis | 1.8 | — | — | — | — | 3.0 | 0.1 | 25.9 | 0.5 | 26.1 | 0.5 |
Providencia | 1.7 | 24.2 | 0.4 | 87.3 | 1.5 | 18.4 | 0.3 | 23.1 | 0.4 | 18.9 | 0.3 |
Pondered Resistance (%) | 15.9 | 14.9 | 12.6 | 25.2 | 16.8 | ||||||